IL6 and acute respiratory distress syndrome: There are currently multiple clinical trials attempting to elucidate the role of anti-IL6 therapies to attenuate ARDS in COVID-19 (clinicaltrials.gov: NCT 00531856; NCT04363853; NCT04335071).